Ryan D Maynard Insider Trading
Get free email notifications about insider trading for Ryan D Maynard.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ryan D Maynard. Ryan D Maynard is a EVP & CFO in RIGEL PHARMACEUTICALS INC ($RIGL) and a VP, CFO in RIGEL PHARMACEUTICALS INC ($RIGL) and a Director in Lion Biotechnologies, Inc. ($LBIO).
Address: RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO 94080 CA
Companies in which Ryan D Maynard is an Insider
IOVANCE BIOTHERAPEUTICS, INC.
Trading Symbol: IOVAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Ryan D Maynard: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 17 2015
$IOVA Market Capitalization: $437.71M
$IOVA Previous Close: $7.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RIGEL PHARMACEUTICALS INC
Trading Symbol: RIGLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Ryan D Maynard: EVP & CFO, VP, CFO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 28 2015
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Ryan D Maynard
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2015 | LBIO | Lion Biotechnologi ... | Maynard Ryan D | Director | Option Exercise | A | 7.45 | 50,000 | 372,500 | 50,000 | |
Jan 28 2015 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 2.14 | 175,000 | 374,500 | 175,000 | |
Mar 03 2014 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 3.59 | 125,000 | 448,750 | 125,000 | |
Jan 31 2013 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | A | 6.51 | 150,000 | 976,500 | 150,000 | |
Sep 14 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Option Exercise | M | 6.49 | 23,302 | 151,230 | 73,300 | |
Sep 14 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Sell | S | 10.67 | 23,302 | 248,560 | 0 | 23.3 K to 0 (-100.00 %) |
Sep 14 2012 | RIGL | RIGEL PHARMACEUTIC ... | Maynard Ryan D | EVP & CFO | Buy | M | 6.49 | 23,302 | 151,230 | 23,302 | 0 to 23.3 K |